Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. (ENTA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENTA · as of Jun 8, 2026
Key Statistics
Explore Enanta Pharmaceuticals, Inc. Data
enta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 73.7%
The ENTA analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $48.20, representing +335.41% upside from the current price of $11.07.
Competitors & Peers
enta competitorsENTA
ASMB
AVIR
CRBU
FHTX
IMRXStock Performance
Full HistoryAbout Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its re…
what is enanta pharmaceuticals, inc. · enta stock overview · enanta pharmaceuticals, inc. company profile · who is enanta pharmaceuticals, inc. ceo · enta NASDAQ · enanta pharmaceuticals, inc. headquarters · enanta pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Enanta Pharmaceuticals, Inc. (ENTA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 21, 2013. As of the latest trading session, ENTA stock price is $11.07, with a market capitalization of $257.0M. The stock has returned +47.60% over the past 12 months and -29.80% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Enanta Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $48.20. In fiscal year 2025, Enanta Pharmaceuticals, Inc. reported revenue of $65.3M and net income of -$81.9M. For detailed data — including Enanta Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Enanta Pharmaceuticals, Inc. (ENTA) stock price is $11.07. The stock is traded on NASDAQ under the ticker symbol ENTA. The 52-week range is $6.43 – $17.15.